İktiyozis ve D Vitamini
Özet
İktiyoz (balık pulu hastalığı) ile D vitamini (Vit D) metabolizması arasındaki ilişkiyi inceleyen tıbbi metinlerde, kornifikasyon bozukluklarının patofizyolojisi ve tedavi yaklaşımları ele alınmaktadır. İktiyozlu hastalarda epidermisteki hiperkeratoz ve skuamlar deri kalınlığını artırarak ultraviyole B (UVB) ışınlarının penetrasyonunu azaltmakta, bu durum de novo Vit D sentezini engellemektedir. Hastaların kozmetik nedenlerle derilerini gizlemesi ve ısı intoleransı sebebiyle güneşten kaçınması Vit D eksikliğini derinleştirmektedir. Konjenital iktiyozlu çocuklarda Vit D eksikliği prevalansı %80-97 oranlarında seyretmekte; sekonder hiperparatiroidizm ile klinik veya radyolojik raşitizm gelişimine yol açabilmektedir. Tedavide, Vit D eksikliği saptanan çocuklara haftalık 60.000 IU kolekalsiferol ve kalsiyum takviyesi önerilirken, yüksek doz oral Vit D replasmanının skuam miktarı ve ekstremite sertliğinde belirgin klinik iyileşme sağladığı gösterilmiştir. Topikal alanda kalsipotriol ve maksakalsitol gibi Vit D3 analogları, proliferatif ve konjenital iktiyoz formlarında (lameller iktiyoz, epidermolitik iktiyoz, Netherton sendromu) keratinosit proliferasyonunu baskılayıp epidermal farklılaşmayı düzenleyerek skuam ve eritemi azaltmada etkili olurken, iktiyozis vulgaris gibi retansiyon tiplerinde etkinlikleri sınırlı kalmaktadır. Sonuç olarak, kalıtımsal iktiyozlu hastalarda Vit D düzeylerinin sistematik taranması ve ömür boyu raşitizm profilaksisi uygulanması hayati önem taşımaktadır.
Medical literature focusing on the relationship between ichthyosis and vitamin D (Vit D) metabolism highlights the pathophysiology and therapeutic approaches of cornification disorders. In patients with ichthyosis, hyperkeratosis and scales increase skin thickness and reduce ultraviolet B (UVB) light penetration, thereby impairing de novo Vit D synthesis in the epidermis. Patients frequently conceal their skin with clothing due to cosmetic concerns and avoid sunlight because of heat intolerance, which further exacerbates Vit D deficiency. The prevalence of Vit D deficiency in children with congenital ichthyosis ranges between 80-97%, frequently leading to secondary hyperparathyroidism and the development of clinical or radiological rickets. Regarding management, weekly administration of 60,000 IU cholecalciferol along with calcium supplementation is recommended for Vit D-deficient children, and high-dose oral Vit D replacement has been shown to yield significant clinical improvements in scaling and limb stiffness. Topically, Vit D3 analogs such as calcipotriol and maxacalcitol are highly effective in reducing scales and erythema in proliferative and congenital ichthyosis forms (lamellar ichthyosis, epidermolytic ichthyosis, and Netherton syndrome) by suppressing keratinocyte proliferation and regulating epidermal differentiation, whereas their efficacy remains limited in retention types like ichthyosis vulgaris. Consequently, systematic screening of Vit D levels and lifelong rickets prophylaxis are crucial in managing patients with hereditary ichthyosis.
Referanslar
Shwayder T, Ott F. All about ichthyosis. Pediatr Clin North Am. 1991;38(4):835-57.
Traupe H. The ichthyosis: a guide to clinical diagnosis, genetic counseling, and therapy. Berlin: Springer Verlag, 1989: 111-34.
Arin MJ. The molecular basis of human keratin disorders. Hum Genet 2009;125:355-73.
Richard G, Rinpfeil F. Ichthyosis, erythrokeratodermas and related disoerders. In: Bolognia JL, Jorizzo JL, Rapini RP, et al eds. Dermatology. 2 nd ed. İspanya: Mosby; 2008: 743-76.
Karaduman A. Kalıtsal Keratinizasyon Bozuklukları. Türkderm. 2011; 45 Özel Sayı 2: 73-80.
Oji V, Tadini G, Akiyama M, et al. Revised nomenclature and classification of inherited ichthyosis: Results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol 2010, 63:607–41.
Oji V, Traupe H. Ichthyosis: clinical manifestations and practical treatment options. Am J Clin Dermatol. 2009;10(6):351-64.
Mazereeuw-Hautier J, Dreyfus I, Barbarot S, et al. Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study in adults using focus groups. Br J Dermatol. 2012;166(3):646-8.
Digiovanna JJ, Mauro T, Milstone LM, et al. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26(1):26-3.
Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr. 1995;61:638–45.
Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: integral components of the vitamin D endocrine system. Am J Clin Nutr 1998; 67:1108–10.
Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocrine Rev. 2001;22:477–501.
Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003;89:552–72.
Bickle DD, Chang S, Crumrine D et al. 25 Hydroxyvitamin D1 α -hydroxylase is required for optimal epidermal differentiation and permeability barrier homeostasis. J Invest Dermatol 2004;122: 984–92.
Staberg B, Oxholm A, Klemp P et al. Abnormal vitamin D metabolism in patients with psoriasis. Acta Derm Venereol 1987; 67:65–8.
Thacher TD, Fischer PR, Pettifor JM et al. Nutritional rickets in ichthyosis and response to calcipotriene. Pediatrics 2004;114:119–23.
Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73–8.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society: Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011, 96:1911–30.
Hanley DA, Cranney A, Jones G, et al. Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada: Vitamin D in adult health and disease: a review and guideline statement from Osteoporosis Canada. CMAJ 2010, 182:610–8.
Holick MF. Vitamin D Deficiency. N Engl J Med. 2007;357:266–81.
Milestone LM, Ellison AF, Insogna KL. Serum parathyroid hormone level is elevated in some patients with disorder of keratinization. Arch Dermatol. 1992;128:926–30.
Smith EL. Walworth NC. Holick MF. Effect of 1.25-dihydroxyvitamin D, on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in scrum-free conditions. J Invest Dermatol 1986;86:709-14.
Souberbielle J-C, Prié D, Courbebaisse M, et al. Update on vitamin D and evaluation of vitamin D status. Ann Endocrinol 2008; 69:501–10.
Melamel ML, Michos ED, Post W, et al. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37.
Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347(1-2):80–9.
Lu J, Goldstein KM, Chen P, et al. Transcriptional profi ling of keratinocytes reveals a vitamin D-regulated epidermal differentiation network. J Invest Dermatol. 2005;124(4):778–85.
Sethuraman G, Khaitan BK, Dash SS, et al. Ichthyosiform erythroderma with rickets: Report of five cases. Br J Dermatol 2008;158:603-6.
Milstone LM, Ellison AF, Karl RN. Serum parathyroid hormone level is elevated in some patients with disorders of keratinization. Arch Dermatol 1992; 128: 926–30.
Perosa A, Sardella L, Acqua Fredda A, et al. Epidermolytic ichthyosis and rickets. Eur J Pediatr Dermatol 2004;14:13–6.
Chouhan K, Sethuraman G, Gupta N, et al. Vitamin D deficiency and rickets in children and adolescents with ichthyosiform erythroderma in type IV and V skin. Br J Dermatol 2012;166:608-15.
Sethuraman G, Sreenivas V, Yenamandra VK, et al. Threshold levels of 25-hydroxyvitamin D and parathyroid hormone for impaired bone health in children with congenital ichthyosis and type IV and V skin. Br J Dermatol 2015;172:208-14.
Ingen-Housz-Oro S, Boudou P, Bergot C, et al. Evidence of a marked 25-hydroxyvitamin D deficiency in patients with congenital ichthyosis. J Eur Acad Dermatol Venereol 2006;20:947–52.
Frascari F, Dreyfus I, Rodriguez L et al. Prevalence and risk factors of vitamin D deficiency in inheritedichthyosis: a French prospective observational study performed in a reference center. Orphanet J Rare Dis 2014; 9:127.
Sethuraman G, Marwaha RK, Apoorva C, et al. Vitamin D: A new promising therapy for congenital ichthyosis. Pediatrics 2016; 137:1-5
Marwaha RK, Tandon N, Reddy DR, et al. Vitamin D and bone mineral density status of healthy schoolchildren in northern India. Am J Clin Nutr 2005;82:477-82.
Mazereeuw-Hautier J, Hernández-Martín A, O'Toole E, et al. Management of congenital ichthyoses: European guidelines of care: Part Two. Br J Dermatol 2019;180(3):484-95.
Rodríguez-Manchón S, Pedrón-Giner C, Cañedo-Villarroya E, et al. Malnutrition in children with ichthyosis: Recommendations for monitoring from a multidisciplinary clinic experience. J Am Acad Dermatol. 2021;85(1):144-51.
Milstone LM, Bale SJ, Insogna KL. Secondary hyperparathyroidism in patients with ichthyosis is not caused by vitamin D deficiency or ingestion of retinoids. Arch Dermatol 1993;129:648.
DiGiovanna JJ, Robinson-Bostom L. Ichthyosis: etiology, diagnosis, and management. Am J Clin Dermatol. 2003;4(2):81-95.
Mondal K, Seth A, Marwaha RK, et al. A randomized controlled trial on safety and efficacy of single intramuscular versus staggered oral dose of 600 000 IU Vitamin D in treatment of nutritional rickets. J Trop Pediatr 2014;60:203-10.
Aggarwal V, Seth A, Marwaha RK, et al. Management of nutritional rickets in Indian children: A
Garg MK, Marwaha RK, Khadgawat R, et al. Efficacy of Vitamin D loading doses on serum 25-hydroxy Vitamin D levels in school going adolescents: An open label non-randomized prospective trial. J Pediatr Endocrinol Metab 2013;26:515-23.
Sethuraman G, Marwaha RK. Vitamin D, bone health and congenital ichthyosis. Indian J Dermatol Venereol Leprol. 2016;82(3):249-51.
Misra M, Pacaud D, Petryk A, et al. Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. Vitamin D deficiency in children and its management: Review of current knowledge and recommendations. Pediatrics 2008;122:398-417.
Sun J, Linden K. Netherton syndrome: a case report and review of the literature. Int J Dermatol. 2006;45:693-7.
Wacker M, Holick MF. Vitamin D effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5:111-48.
Cao X, Lin Z, Yang H, et al. New mutations in the transglutaminase 1 gene in three families with lamellar ichthyosis. Clin Exp Dermatol. 2009;34(8):904-9.
Judge MR, McLean WHI, Munro CS. Disorders of keratinization. In: Rook’s Textbook of Dermatology (Burns T, Breathnach S, Cox N, Griffiths C, eds), 8th edn. Oxford: Wiley Blackwell; 2010:19.1-19.122.
Kothari D, Doshi B, Garg G, et al. Ichthyosis associated with rickets in two Indian children. Indian J Dermatol 2013;58:244.
Ali R, Aman S, Nadeem M. Lamellar ichthyosis with rickets. Pak J Med Sci. 2013;29(2):660-2.
Zaouak A, Abdessalem G, Mkaouar R, et al. Congenital lamellar ichthyosis in Tunisia associated with vitamin D rickets caused by a founder nonsense mutation in the TGM1 gene. Int J Dermatol. 2019;58(7):135-7.
Okano M, Kitano Y, Yoshikawa K. A trial of oral 1 alpha-hydroxyvitamin D3 for ichthyosis. Dermatologica. 1988;177(1):23.
Malloy PJ, Xu R, Peng L, et al. Hereditary 1,25- dihydroxyvitamin D resistant rickets due to a mutation causing multiple defects in vitamin D receptor function. Endocrinology 2004;145:5106–14.
el-Khateeb EA. Bullous congenital ichthyosiform erythroderma associated with hypocalcemic vitamin D-resistant rickets. Pediatr Dermatol. 2008;25(2):279-82.
Deka N, Sarma D, Saikia UK. Lamellar ichthyosis with genu valgum: unfolding the link. BMJ Case Rep 2012; 22: 2012.
Navarro-Triviño FJ, Arias-Santiago S, Gilaberte-Calzada Y. Vitamin D and the Skin: A Review for Dermatologists. Actas Dermosifiliogr. 2019;110(4):262-72.
Ashcroft DM, Po AL, Williams HC, et al. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 2000;320:963-7.
Berth-Jones J, Hutchinson PE. Vitamin D analogues and psoriasis. Br J Dermatol 1992;127:71-8,
Kragballe K, Steijlen PM, Ibsen HH, et al. Efficacy, tolerability, and safety of caicipotriol ointment in disorders of keratinization: results of a randomized, double-blind, vehicle-controlled, right/ left comparative study. Arch Dermatol 1995;131:556-60.
Delfino M, Fabbrocini G, Sammarco E, et al. Efficacy of caicipotriol versus lactic acid cream in the treatment of lamellar and X-linked ichthyoses. J Dermatol Treat 1994;5:151-2.
Lucker GP, van de Kerkhof PC, van Dijk MR, et al. Effect of topical calcipotriol on congenital ichthyosis. Br J Dermatol 1994; 131(4): 546–50.
Godic A, Dragos V. Successful treatment of Netherton's syndrome with topical caicipotriol. Eur J Dermatol 2004;14:115-7.
Fernandez-Vozmediano JM, Armario-Hita JC, Conzalez-Cabrerizo A. Sjogren-Larsson syndrome: treatment with topical caicipotriol. Pediatr Dermatol 2003;20:179-80.
Lucker GP, van de Kerkhof PC, Cruysberg JR, et al. Topical treatment of Sjogren-Larsson syndrome with calcipotriol. Dermatology 1995;190:292-4.
Bogenrieder T, Landthaler M, Stolz W. Bullous congenital ichthyosiform erythroderma: safe and effective topical treatment with caicipotriol ointment in a child. Acta Derm Venereol 2003; 83:52-4.
Umekoji A, Fukai K, Ishii M. A case of mosaic-type bullous congenital ichthyosiform erythroderma successfully treated with topical maxacalcitol, a vitamin D3 analogue. Clin Exp Dermatol 2008;33:501-2.
Okano M. Assessment of the clinical effect of topical tacalcitol on ichthyoses with retentive hyperkeratosis. Dermatology 2001;202: 116-8.
Barker JN, Ashton RE, Marks R, et al. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol 1999; 141: 274–8.
Traupe H. The Sjögrcn-Larsson syndrome; in Traupe H (cd): The Ichthyoses. Berlin, Springer. 1989: 157-62.
Wat H, Dytoc M. Off-label uses of topical vitamin D in dermatology: a systematic review. J Cutan Med Surg. 2014;18(2):91-108.
Griffiths WAD, Judge MR, Liegh IM. Disorders of keratinization. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook's Textbook of Dermatology. 6th ed. Oxford: Blackwell Science; 1998: 1483–588.
El Hag Al, Karrar ZA. Nutritional vitamin D deficiency rickets in Sudanese children. Ann Trop Pediatr. 1995;15:69–76.
Madhusmita M, Pacaud D, Collett-Solberg PF, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122:398-417.
